Clinical Advances in Nasopharyngeal Carcinoma - Episode 1

Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach

, ,

Experts on nasopharyngeal carcinoma (NPC) provide an overview of the disease, highlighting its incidence, how it’s differentiated from other head and neck cancers, and the benefits of multidisciplinary care.

Now Viewing
EP. 1: Differentiating Nasopharyngeal Carcinoma from Other Head & Neck Cancers: The Value of a Multidisciplinary Approach
EP. 2: Current Guidelines for Managing Nasopharyngeal Carcinoma
EP. 3: Overview of the JUPITER and POLARIS-2 Trials
EP. 4: Value of PD-L1 Biomarker in NPC
EP. 5: Phase 3 DIPPER Trial: Adjuvant PD-1 Blockade with Camrelizumab
EP. 6: Tailoring NPC Treatment: Patient Populations, EBV Titer Monitoring, and Key External Factors
EP. 7: Strategies to Mitigate Adverse Events in Nasopharyngeal Carcinoma Treatment
EP. 8: Future Research Needs for Neoadjuvant/Adjuvant PD-1 Blockade in Nasopharyngeal Carcinoma
EP. 9: Integrating PD-1 Inhibitors into Standard NPC Treatment: Potential Benefits and Future Prospects
EP. 10: Clinical Scenario: Locally Recurrent NPC

Video content above is prompted by the following:

  • Briefly explain how nasopharyngeal carcinoma (NPC) is differentiated from other head and neck cancers.
    • Please comment on the potential benefit of a multidisciplinary approach in treating this disease.